People say "submit your dossier" as though it's a single document. It isn't. A pharmaceutical registration dossier is a structured file built from five distinct modules, each with its own content requirements — and a gap in any one of them can hold up the entire submission, regardless of how strong the rest of the file is.
The CTD standard
Ghana FDA requires dossiers in Common Technical Document (CTD) format — the internationally harmonised structure developed under the International Council for Harmonisation (ICH), and the same standard used by regulators in the EU and US. Working in CTD format is not just a Ghana-specific requirement; it's the reason a well-built dossier for one market can often be adapted, rather than rebuilt from scratch, for another.
The five modules, in practical terms
Module 1 — Administrative and regional information. Application forms, prescribing information, labelling, and country-specific documents: the Certificate of Pharmaceutical Product, GMP evidence, local representative details. This is the one module that differs by country — it's built specifically for Ghana FDA, not reused unchanged from another market's submission.
Module 2 — Summaries. Overviews and summaries of the quality, nonclinical and clinical data that follows in Modules 3–5, giving reviewers a structured entry point into the full file.
Module 3 — Quality. Manufacturing information, specifications, analytical methods, and — critically for Ghana's climate — stability data. This is typically the largest and most technically dense module, and the one where formatting or completeness gaps most often trigger queries.
Module 4 — Nonclinical (safety) data. Required in full for new chemical entities; for established, well-characterised active ingredients, this module is typically referenced rather than rebuilt from scratch.
Module 5 — Clinical (efficacy) data. Clinical study data supporting the product's efficacy and safety in use, scoped according to the product's regulatory history and category.
Where Ghana-specific requirements sit
Because Modules 2 through 5 are broadly harmonised across CTD-using regulators, most of the Ghana-specific work in a dossier concentrates in Module 1 and in the stability data within Module 3 — where FDA's climatic zone requirements for tropical, high-humidity conditions apply. Getting these two areas right is usually what separates a dossier built generically from one built specifically for Ghana.
Building or reviewing a CTD dossier for Ghana?
We build complete, review-ready dossiers so nothing is missing when your file reaches the FDA's desk.
Start your engagement →